TrialAntimicrobial agents and chemotherapy2017

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers.

Jeremy J Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.